AZD-0233

N/A

Report date: 2026/01/27 20:00:10
NME

Base Information

Drug NameAZD-0233
Drug Alias NameAZD0233AZD-0233
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionC-X3-C motif chemokine receptor 1 modulators
TargetsC-X3-C motif chemokine receptor 1
Therapy Area/IndicationsCardiomyopathy, Dilated
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstrazeneca Plc
Active IndicationsN/A
Inactive IndicationsCardiomyopathy, Dilated

Other Information

ATC CodeN/A
Related LinksN/A